vs

Side-by-side financial comparison of Teladoc Health, Inc. (TDOC) and Virtu Financial, Inc. (VIRT). Click either name above to swap in a different company.

Virtu Financial, Inc. is the larger business by last-quarter revenue ($969.9M vs $642.3M, roughly 1.5× Teladoc Health, Inc.). On growth, Virtu Financial, Inc. posted the faster year-over-year revenue change (16.3% vs 0.3%). Virtu Financial, Inc. produced more free cash flow last quarter ($495.6M vs $85.1M). Over the past eight quarters, Virtu Financial, Inc.'s revenue compounded faster (22.8% CAGR vs -0.3%).

Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company headquartered in New York, New York, United States that was founded in 2002. Primary services include telehealth, medical opinions, AI and analytics, telehealth devices and licensable platform services. In particular, Teladoc Health uses telephone and videoconferencing software as well as mobile apps to provide on-demand remote medical care.

Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.

TDOC vs VIRT — Head-to-Head

Bigger by revenue
VIRT
VIRT
1.5× larger
VIRT
$969.9M
$642.3M
TDOC
Growing faster (revenue YoY)
VIRT
VIRT
+16.0% gap
VIRT
16.3%
0.3%
TDOC
More free cash flow
VIRT
VIRT
$410.5M more FCF
VIRT
$495.6M
$85.1M
TDOC
Faster 2-yr revenue CAGR
VIRT
VIRT
Annualised
VIRT
22.8%
-0.3%
TDOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TDOC
TDOC
VIRT
VIRT
Revenue
$642.3M
$969.9M
Net Profit
$139.9M
Gross Margin
Operating Margin
-5.6%
35.4%
Net Margin
14.4%
Revenue YoY
0.3%
16.3%
Net Profit YoY
48.7%
EPS (diluted)
$-0.14
$1.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TDOC
TDOC
VIRT
VIRT
Q4 25
$642.3M
$969.9M
Q3 25
$626.4M
$824.8M
Q2 25
$631.9M
$999.6M
Q1 25
$629.4M
$837.9M
Q4 24
$640.5M
$834.3M
Q3 24
$640.5M
$706.8M
Q2 24
$642.4M
$693.0M
Q1 24
$646.1M
$642.8M
Net Profit
TDOC
TDOC
VIRT
VIRT
Q4 25
$139.9M
Q3 25
$-49.5M
$77.6M
Q2 25
$-32.7M
$151.2M
Q1 25
$-93.0M
$99.7M
Q4 24
$94.1M
Q3 24
$-33.3M
$60.0M
Q2 24
$-837.7M
$66.6M
Q1 24
$-81.9M
$55.8M
Operating Margin
TDOC
TDOC
VIRT
VIRT
Q4 25
-5.6%
35.4%
Q3 25
-8.3%
21.8%
Q2 25
-8.6%
34.7%
Q1 25
-19.2%
26.7%
Q4 24
-7.5%
24.3%
Q3 24
-6.9%
20.8%
Q2 24
-130.9%
22.4%
Q1 24
-13.5%
21.8%
Net Margin
TDOC
TDOC
VIRT
VIRT
Q4 25
14.4%
Q3 25
-7.9%
9.4%
Q2 25
-5.2%
15.1%
Q1 25
-14.8%
11.9%
Q4 24
11.3%
Q3 24
-5.2%
8.5%
Q2 24
-130.4%
9.6%
Q1 24
-12.7%
8.7%
EPS (diluted)
TDOC
TDOC
VIRT
VIRT
Q4 25
$-0.14
$1.54
Q3 25
$-0.28
$0.86
Q2 25
$-0.19
$1.65
Q1 25
$-0.53
$1.08
Q4 24
$-0.27
$1.03
Q3 24
$-0.19
$0.64
Q2 24
$-4.92
$0.71
Q1 24
$-0.49
$0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TDOC
TDOC
VIRT
VIRT
Cash + ST InvestmentsLiquidity on hand
$781.1M
$1.1B
Total DebtLower is stronger
$2.0B
Stockholders' EquityBook value
$1.4B
$1.6B
Total Assets
$2.9B
$20.2B
Debt / EquityLower = less leverage
1.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TDOC
TDOC
VIRT
VIRT
Q4 25
$781.1M
$1.1B
Q3 25
$726.2M
$707.9M
Q2 25
$679.6M
$752.1M
Q1 25
$1.2B
$723.6M
Q4 24
$1.3B
$872.5M
Q3 24
$1.2B
$701.4M
Q2 24
$1.2B
$684.8M
Q1 24
$1.1B
$399.6M
Total Debt
TDOC
TDOC
VIRT
VIRT
Q4 25
$2.0B
Q3 25
$2.0B
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
$1.7B
Q3 24
$1.7B
Q2 24
$1.7B
Q1 24
$1.7B
Stockholders' Equity
TDOC
TDOC
VIRT
VIRT
Q4 25
$1.4B
$1.6B
Q3 25
$1.4B
$1.5B
Q2 25
$1.4B
$1.4B
Q1 25
$1.4B
$1.3B
Q4 24
$1.5B
$1.3B
Q3 24
$1.5B
$1.2B
Q2 24
$1.5B
$1.2B
Q1 24
$2.3B
$1.2B
Total Assets
TDOC
TDOC
VIRT
VIRT
Q4 25
$2.9B
$20.2B
Q3 25
$2.9B
$21.3B
Q2 25
$2.9B
$19.3B
Q1 25
$3.4B
$17.5B
Q4 24
$3.5B
$15.4B
Q3 24
$3.5B
$14.4B
Q2 24
$3.5B
$13.9B
Q1 24
$4.3B
$12.8B
Debt / Equity
TDOC
TDOC
VIRT
VIRT
Q4 25
1.29×
Q3 25
1.40×
Q2 25
1.24×
Q1 25
1.33×
Q4 24
1.39×
Q3 24
1.41×
Q2 24
1.41×
Q1 24
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TDOC
TDOC
VIRT
VIRT
Operating Cash FlowLast quarter
$87.7M
$518.4M
Free Cash FlowOCF − Capex
$85.1M
$495.6M
FCF MarginFCF / Revenue
13.3%
51.1%
Capex IntensityCapex / Revenue
0.4%
2.4%
Cash ConversionOCF / Net Profit
3.71×
TTM Free Cash FlowTrailing 4 quarters
$285.5M
$485.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TDOC
TDOC
VIRT
VIRT
Q4 25
$87.7M
$518.4M
Q3 25
$99.3M
$-68.7M
Q2 25
$91.4M
$62.8M
Q1 25
$15.9M
$15.0M
Q4 24
$85.9M
$599.0M
Q3 24
$110.2M
$112.1M
Q2 24
$88.7M
$490.8M
Q1 24
$8.9M
$-395.4M
Free Cash Flow
TDOC
TDOC
VIRT
VIRT
Q4 25
$85.1M
$495.6M
Q3 25
$97.0M
$-76.7M
Q2 25
$90.2M
$57.6M
Q1 25
$13.2M
$9.2M
Q4 24
$79.8M
$586.6M
Q3 24
$108.6M
$106.2M
Q2 24
$86.8M
$486.9M
Q1 24
$7.8M
$-398.2M
FCF Margin
TDOC
TDOC
VIRT
VIRT
Q4 25
13.3%
51.1%
Q3 25
15.5%
-9.3%
Q2 25
14.3%
5.8%
Q1 25
2.1%
1.1%
Q4 24
12.5%
70.3%
Q3 24
17.0%
15.0%
Q2 24
13.5%
70.3%
Q1 24
1.2%
-61.9%
Capex Intensity
TDOC
TDOC
VIRT
VIRT
Q4 25
0.4%
2.4%
Q3 25
0.4%
1.0%
Q2 25
0.2%
0.5%
Q1 25
0.4%
0.7%
Q4 24
1.0%
1.5%
Q3 24
0.2%
0.8%
Q2 24
0.3%
0.6%
Q1 24
0.2%
0.4%
Cash Conversion
TDOC
TDOC
VIRT
VIRT
Q4 25
3.71×
Q3 25
-0.89×
Q2 25
0.42×
Q1 25
0.15×
Q4 24
6.37×
Q3 24
1.87×
Q2 24
7.37×
Q1 24
-7.08×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TDOC
TDOC

Teladoc Health Integrated Care$409.1M64%
Better Help$233.2M36%

VIRT
VIRT

Segment breakdown not available.

Related Comparisons